Stockreport

Surrozen Provides Second Quarter 2024 Financial Results and Business Update

Surrozen, Inc.  (SRZN) 
PDF Enrollment ongoing in SZN-043 Phase 1b trial in patients with Severe Alcoholic Hepatitis Presented first-in-human data from SZN-043 Phase 1a trial at EASL Published st [Read more]